Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysis.
Innocent Gerald AsiimweSudeep PushpakomRichard M TurnerRuwanthi Kolamunnage-DonaAndrea L JorgensenMunir PirmohamedPublished in: British journal of clinical pharmacology (2021)
Cardiovascular drugs are not associated with poor COVID-19 outcomes in adjusted analyses. Patients should continue taking these drugs as prescribed.